Both in Diagnostics
Q/C Technologies vs Immucell
Over the past year QCLS returned −86.9% and ICCC returned +72.8%; their daily moves had a correlation of -0.01.
QCLS −86.9% ICCC +72.8%Growth of $1, one year, split-adjusted
| Metric | QCLS | ICCC |
|---|---|---|
| Price | $0.3910 | $10.37 |
| Market cap | $3.2M | $94.2M |
| Today | −8.00% | +1.17% |
| 1 month | −43.3% | +4.0% |
| 6 months | −90.2% | +19.7% |
| Year to date | −90.2% | +68.6% |
| 1 year | −88.4% | +67.0% |
| Revenue growth (YoY) | — | +11.5% |
| Gross margin | — | 33.9% |
| Net margin | — | 25.5% |
| P/E (TTM) | — | 119.6× |
| Price / sales | — | 3.1× |
| Net cash | $11.0M | $557.3K |
| Dividend yield | — | — |
| Volatility (60d) | 297.5% | 38.4% |
| Short % of float | 12.2% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).